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Abstract: (1) Objective: To evaluate the effectiveness of non-immersive virtual reality in reducing
falls and improving balance in patients diagnosed with Parkinson’s disease. (2) Methods: The
following databases were searched: PUBMED, PEDro, Scielo, CINAHL, Web of Science, Dialnet,
Scopus and MEDLINE. These databases were searched for randomized controlled trials published
using relevant keywords in various combinations. The methodological quality of the articles was
evaluated using the PEDro scale. (3) Results: A total of 10 studies with a total of 537 subjects, 58.7%
of which (n = 315) were men, have been included in the review. The age of the participants in
these studies ranged between 55 and 80 years. Each session lasted between 30 and 75 min, and the
interventions lasted between 5 and 12 weeks. These studies showed that non-immersive virtual
reality is effective in reducing the number of falls and improving both static and dynamic balance in
patients diagnosed with Parkinson’s disease. Results after non-immersive virtual reality intervention
showed an improvement in balance and a decrease in the number and the risk of falls. However, no
significant differences were found between the intervention groups and the control groups for all the
included studies regarding balance. (4) Conclusions: There is evidence that non-immersive virtual
reality can improve balance and reduce the risk and number of falls, being therefore beneficial for
people diagnosed with Parkinson’s disease.
Keywords: rehabilitation; Parkinson’s disease; VR; virtual reality; non-immersive; risk of falls; balance
1. Introduction
Parkinson’s disease (PD) is a chronic, progressive condition characterized by the loss
of dopaminergic neurons located in the substantia nigra of the Pars Compacta (SNpc) of the
midbrain, which eventually leads to depletion of the neurotransmitter dopamine in the
basal ganglia [1,2]. It is considered the second most common neurodegenerative disorder,
and affects 2%–3% of the population over 65 years of age [3,4]. The quality of life of patients
with PD decreases considerably due to changes in both motor and non-motor functions.
The resulting functional disability places a considerable physical and mental burden on
family members and caregivers [5]. The clinical manifestations of PD are characterized
by slow movements, resting tremor and rigidity, together with non-motor manifestations.
The most common feature of PD is bradykinesia, a progressive slowness in carrying out
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movements, including difficulties for planning, initiating and executing tasks that require
simultaneous and sequential movements, such as ambulation [6].
This leads to postural instability typical of PD, and largely contributes to the high risk
of falls in PD patients [7]. Losing their ability to keep their balance while standing also
undermines patients’ quality of life and their functionality, and considerably increases the
risk of falls [8]. As the disease progresses, PD patients lose postural stability, which in turn
causes gait disorders and limitations in their basic, instrumental and advanced activities of
daily living [9]. Although motor abnormalities such as resting tremor may improve with
medication, other symptoms such as postural instability while standing do not respond to
medication and require alternative therapeutic approaches [10].
Currently, the most widely used pharmacological treatment to manage the motor
symptoms associated with PD is dopamine replacement and/or dopamine agonist ther-
apy [11]. Treatment with L-Dopa improves patient quality of life by alleviating the motor
symptoms associated with dopamine depletion [12]. However, since neuronal death con-
tinues, L-dopa must be successively up-dosed, and it usually loses its effectiveness after
several years of chronic use. Chronic (5–10 years) treatment with L-Dopa also causes certain
side effects, such as dyskinesia [13], hence the importance of introducing new therapeutic
interventions that can diminish the impact of dyskinesia in PD [14].
Various therapies are being used as complement to pharmacological treatment in PD,
such as: physical activity [15], deep brain stimulation (DBS) [16], transcranial magnetic
stimulation (TMS) [17], cell replacement [18] or virtual reality therapy [19]. The latter is
one of the latest techniques in the field of neurorehabilitation, ageing and disability [20].
Virtual reality (VR) is defined as a 3-dimensional (3D) computer generated environ-
ment in which the user is able to see, hear or manipulate the contents of such artificial
environment [21]. The 3D environments can vary depending on their level of immersion.
VR can be classified as immersive, semi-immersive and non-immersive [22]. The last two
have been named “non-immersive” due to the lack of fully multisensory simulation, and
the user still perceives some information from the real world [23]. Thus, in non-immersive
VR systems (NIVR), subjects interact with a scenario displayed on a screen, but do not
become completely immersed because they are able to perceive the real world together
with the digital images. Most of these systems can use a joystick to interact with a PC
or tablet [24]. Semi-immersive VR takes the subjects to a partially immersive scenario
displayed on a screen, and frequently they able to interact with the digital scene through
body movements. The disadvantage of this type of simulations is that users are susceptible
to environmental distractions [25]. Some examples of devices used in semi-immersive VR
are: Holobench, IMAX, DOMES and Inmersadesk [26].
Nevertheless, non-immersive systems traditionally have offered a number of advan-
tages over immersive VR, such as low cost and user-friendliness, since they permit an
individual to maintain contact with the real world [27].
One of the main advantages of VR systems is that they allow to develop different
intervention protocols in which the therapist can change the content, duration, intensity and
feedback. It is even possible to use VR technology in combination with other applications,
such as brain-computer interface (BCI) technology that make possible to control avatars
or objects in video games [28]. This training model is being used to promote neural
reorganization and neuroplasticity, which is key during recovery from various neurological
disorders, such as stroke, multiple sclerosis or infantile cerebral palsy (PCI), among others,
and to improve balance and risk of falls [29].
The aim of this systematic review is to determine whether NIVR can be an effective
complement to more conventional neurorehabilitation treatments in terms of improving
postural stability while reducing the risk of falls in patients with PD.
The low cost and user-friendliness of non-immersive VR systems could result in a
useful, and readily available tool for healthcare professionals in charge of rehabilitation of
patients diagnosed with PD.
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2. Materials and Methods
2.1. Study Design
This systematic review has been performed following the recommendations of the
Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) (Moher,
2009) [30] and the Cochrane Handbook for Systematic Reviews of Interventions (Cumpston,
2019) [31]. The methodology of the review was registered in the International Prospective
Register of Systematic Reviews (PROSPERO), under the following number: CRD42021266966
(11 August 2021). Available from: https://www.crd.york.ac.uk/prospero/display_record.
php?ID=CRD42021266966.
2.2. Source Data and Search Strategy
We performed a literature search in PubMed Medline, PEDro (Physiotherapy Evidence
Database), SciELO, CINAHL Complete, Web of Science, Dialnet, and Scopus between May
2021 and August 2021. We also searched the references of full text articles together with
the grey literature (conference abstracts, expert papers and clinical practice guidelines)
for studies published until the moment of the search. The Cochrane Collaboration PICOS
strategy was used to formulate the research question [32]: Is non-immersive virtual reality
an effective strategy for improving balance and reducing the number of falls in Parkinson’s
patients?, as shown in Table 1.
Table 1. PICOS: Participants, Interventions, Comparisons, Outcomes and Study design.












Notes: PD = Parkinson’s Disease; RVNI = non-immersive virtual reality; VR = virtual reality.
On this basis, we created a search strategy using Medline Medical Headings Subjects
(MeSH) keywords, such as: “virtual reality”, “virtual reality exposure therapy”, “parkinson
disease”, “postural balance” and “accidental falls” and synonyms (entry terms). We only
reviewed those articles we had access to the full text. Table 2 shows the search strategy
used for each database.
Table 2. Search strategies used in each database.
Database Search strategy
PubMed Medline
(parkinson disease[mh] OR parkinson disease[tiab] OR parkinson’s disease[tiab] OR
“parkinson”[tiab]) AND (virtual reality[mh] OR virtual reality[tiab] OR virtual reality exposure
therapy[mh] OR “non-immersive virtual reality”[tiab] OR “Nintendo”[tiab] OR “Xbox” [tiab] OR
videogam *[tiab] OR exergame *[tiab]) AND (postural balance[mh] OR postural balance[tiab] OR
“balance”[tiab] OR postural control[tiab] OR accidental falls[mh] OR accidental falls[tiab] OR fall
*[tiab] OR risk of fall *[tiab])
PEDro Parkinson * virtual reality
Web of Science TS = (Parkinson * AND (videogame * OR exergame * OR virtual reality) AND (balance or fall *))
SCOPUS (TITLE-ABS-KEY (parkinson OR “Parkinson’s disease”)) AND (TITLE-ABS-KEY (“virtual reality”OR “exergames”)) AND (TITLE-ABS-KEY (“balance” OR “fall”))
CINAHL
(MH “Parkinson Disease”) AND ((MM “Virtual Reality Exposure Therapy”) OR (MM “Virtual
Reality”) OR (MM “Exergames”)) AND ((MM “Balance, Postural”) OR (MM “Balance Training,
Physical”) OR (MM “Accidental Falls”))
DIALNET Parkinson * AND (“virtual reality” OR exergame *) AND (balance OR fall *)
SciELO Parkinson * AND (“virtual reality” OR exergame *) AND (balance OR fall *)
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2.3. Study Design
We conducted a systematic review of the scientific literature by searching databases for
published studies on the effectiveness of NIVR in preventing falls and improving balance
in patients diagnosed with PD. This was followed by a critical analysis of the scientific
literature retrieved from the literature search.
2.4. Study Screening: Inclusion and Exclusion Criteria
Three researchers performed the identification phase independently (F.A.N-E., I.C.L.-P,
I.C.-P.). All studies selected by at least one of the investigators on the basis of the title and
abstract were included for the final screening. Then, all the selected records were analyzed
by two of these researchers. If consensus was not reached, the decision was made by a
third researcher (A.M.C.-S.).
Studies included in the review had to meet the following inclusion criteria: (1) ran-
domized clinical trial (RCT) or RCT pilot; (2) in which the effect of RVNI was analyzed;
(3) compared to other interventions or simple observation; (4) on balance or risk of falls;
(5) in Parkinson’s patients; and (6) RCTs with a methodological quality >4 on the PEDro
scale. Exclusion criteria were: (1) studies other than RCTs; (2) studies in which the sample
included a range of neurological pathologies apart from Parkinson’s and did not present
their results disaggregated by pathology (3) single group studies.
2.5. Data Extraction
Two investigators (H.G.-L., E.O.-G.) extracted the data from the included studies,
and discrepancies were resolved by consensus. Data were collected on the general char-
acteristics of the study (authorship, year of publication, country and type of study), the
characteristics of the sample (number of groups, participants per group and age of par-
ticipants), the characteristics of the intervention (type of NIVR system, number of weeks,
number of sessions per week, duration of each session and evaluation schedule).
2.6. Outcomes
The main outcome variables analyzed in this review were balance and risk of falls.
Balance was analyzed using the Berg Balance Scale (BBS), the Activities-specific Balance
and Confidence (ABC) scale, the Tinetti scale, and dynamic posturography performed
using the balance master system (NeuroCom International Inc, Clackamas, OR). The risk of
falls and balance confidence were analyzed using the Timed Up and Go Test (TUG) and the
Functional Reach Test (FRT). These instruments have been used for such goal in previous
studies [33,34]. The number of falls was also measured through self-report instruments,
see Table 3.
2.7. Risk of Bias Assessment
The PEDro scale [35,36]—a checklist of 11 yes-or-no questions—was used to assess
the methodological quality and risk of bias of the articles selected for the systematic review.
The final score is the sum of answers 2 to 11, giving a score of between 0 and 10. A study is
“excellent” if it has a score of 9–10; “good quality” if it has a score of 6 to 8 points; “moderate
quality” if it scores between 4 and 5 points, and “low quality” if it scores less than 3. The
eligibility criteria are not used to calculate the final score.
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Table 3. Characteristics of the studies included in the systematic review.
Study Participants(N)
Age
(years) Design Evaluation Outcomes
Measuring
Instrument Results
Del Din et al.




T1 = 6 wk
Number of
falls FRA
The FRA index decreased
significantly in the CG and EG
(p ≤ 0.035).
Pelosin et al.




T1 = 6 w
kT2 = 12 wk
Number of
falls Schedule
The EG and CG showed a
significant time training
interaction (F 1.33 = 7.39,
p = 0.012).
EG = TM + VR reduced the
number of falls (p < 0.001) with
respect to CG = TM.
Santos et al.











differences between GG, EG1 and
EG2 with respect to BBS
(p = 0.968) and TUG (p = 0.824).
Significant differences found in
pre and post intervention
analyses of all outcomes.
The effect size was larger for














After Tx, BBS and TUG scores
improved significantly in both
groups (p < 0.005).
The EG = VR showed improved
performance compared to the
CG = CP on BBS, TUG and
Unified Parkinson’s Disease








T1 = 7 wk










There were significant differences
between the groups, with the
EG = home VR showing
improvement in the BBS
(p = 0.04).
No significant differences
between the groups for ABC and
number of falls.
Significant pre/post-test
differences in EG = home VR with









T1 = 6 wk
T2 = 30 wk
Number of
falls Incidence
The number of falls was lower in
the EG = TM + VR than in the
CG = TM in patients diagnosed








T1 = 5 wk






The post hoc analysis showed
significant differences between
groups in the pre-test, post-test
and follow-up (p < 0.02) on BBS
and FRA, but no significant
difference between the pre-test
and follow-up in the Tinetti test
(p = 0.2) in the EG.
No significant differences
between the intervention groups
(p> 0.005).
The effect size was large in BBS
(d = 0.9); moderate in TT (d = 0.4)
and small in FRA (d < 0.2) after
the intervention.














T1 = 6 wk





Both groups obtained better
results in relation to BBS and TUG
after the intervention and at 8
weeks of follow-up (p < 0.001).
No significant differences
between the groups after the test








T1 = 6 wk Balance BBS
After 6 wk of Tx, BBS improved
significantly in the EG (46.0 ± 1.3
to 48.1 ± 3.0; p < 0.05), but
showed no significant
improvement in the CG










T1 = 6 wk











EG1 and EG2 showed significant
improvements in MV/SOT
compared to the CG after
treatment and at 1 month of
follow-up (p < 0.001).
EG1 and EG2 showed significant
improvements compared to the
CG relative to follow-up
(p < 0.001).
No significant differences
between EG1 and EG2 relative to
FES-I.
EG2 showed significant
improvements in SOT, TUG,
FES-I with respect to CG.
ABC = Activities-specific Balance Confidence Scale; BBS = Berg balance scale; CE = Conventional exercise; CG = Control group; CP = Con-
ventional physiotherapy; EG = Experimental group; FES = Functional electrical stimulation; FES-I = Falls Efficacy Scale; FPE = Fall
prevention education; FRA = fall rates relative to activity exposure index; HE = Healthy elderly patients; HT = Home training; IF = Idio-
pathic falls; MCI = Mild cognitive impairment; MV = Dynamic balance test; NDT = Neurodevelopmental treatment; NW = Nintendo Wii
Fit; OA = Osteoarthritis; TM = Treadmill; TT = Tinetti Test; TUG = Timed Up and Go; Tx = Treatment; SIBT = Sensory Integration Balance
Training; SOT = Sensory organization test; VR = virtual reality; WK = Weeks.
3. Results
3.1. Search Results
The initial search identified 609 potential articles (PubMed Medline, 130; Web of
Science, 266; PEDro, 33; SCOPUS, 152; CINAHL, 18; SciELO, 7; Dialnet, 3), of which 278
were duplicates and therefore excluded, leaving 331 articles to review in full text. After
reviewing the abstract, 270 articles were excluded, leaving 61 articles to be evaluated in full
text due to their eligibility; 51 articles were excluded for the following reasons: different to
RCT (13); does not use NIVR systems (17); and balance or risk of falls are not analyzed (21).
Therefore, 10 studies were included in the systematic review. Figure 1 shows the PRISMA
flow diagram with the different phases of the review [30] (eligibility and data synthesis.
PRISMA flow diagram).
3.2. Characteristics of the Included Studies
A total of 537 participants were included in the 10 studies reviewed. The mean age
of participants was 69 years; and there were 51 dropouts. Participants dropped out or
were withdrawn for the following reasons: change in treatment; loss of interest or low
motivation; personal reasons and adverse events; medical reasons; difficulty in travelling
to the study site; and non-compliance with the treatment protocol. The mean number of
participants in the intervention group after randomization was 28 subjects diagnosed with
PD, with a range of between 10 and 66 subjects; three studies had more than 30 subjects in
the intervention group [37,41,42].




Figure 1. Eligibility and data synthesis: PRISMA flow diagram.
The NIVR rehabilitation protocols differed in terms of the device used, the time per
session and frequency of treatment, and the duration of the intervention. The devices used
were Nintendo Wii Fit [39–41,43,45,46], modified Microsoft Kinect connected to a large
screen [37,38,42] and a custom-created non-immersive VR system consisting of a 22-inch
touch screen and a balance board [44]. In one study, the frequency of treatment differed
between the groups (twice a week for controls and three times a week for the experimental
group) [43]; however, in the remaining nine studies [37–42,44–46] the average frequency
of treatment was three times per week (range three to five times per week). The average
session time using NIVR was 53.5 min (range 30–75 min). Table 4 summarizes interventions
characteristics of the revised studies.
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Table 4. Characteristics of interventions used in the included studies.
Study Intervention Type of NIVR Time per Session Frequency Duration ofTreatment




40 min 3/wk 6 wk




45 min 3/wk 6 wk
Santos et al. (2019) [39]
CG = CE
EG1 = NIVR
EG2 = NIVR + CE
Nintendo Wii Fit 50 min 2/wk 8 wk
Feng et al. (2019) [40] CG = CPEG = NIVR Nintendo Wii Fit 45 min 5/wk 12 wk
Gandolfi et al. (2017) [41] CG = clinical SIBTEG = home NIVR Nintendo Wii Fit 50 min 3/wk 7 wk




45 min 3/wk 6 wk
Negrini et al. (2016) [43] CG = NIVR 10 ssEG = NIVR 15 ss Nintendo Wii Fit 30 min
CG = 2/wk
EG = 3/wk 5 wk
Yang et al. (2016) [44] CG = CE Touch screen 50 min 2/wk 6 wk
EG = home NIVR Virtual balance trainingsystem
Lee et al. (2015) [45] CG = NDT + FESEG = NDT + FES + NIVR Nintendo Wii Fit
45 min
75 min 5/wk 6 wk
Liao et al. (2015) [46]
CG = FPE
Nintendo Wii Fit 60 min 2/wk 6 wkEG1 = CE + TM
EG2 = NIVR + TM
ABC = Activities-specific Balance Confidence Scale; BBS = Berg balance scale; CE = Conventional exercise; CG = Control group; CP = Con-
ventional physiotherapy; EG = Experimental group; FES = Functional electrical stimulation; FES-I = Falls Efficacy Scale; FPE = Fall
prevention education; FRA = fall rates relative to activity exposure index; HE = Healthy elderly patients; HT = Home training; IF = Idio-
pathic falls; MCI = Mild cognitive impairment; MV = Dynamic balance test; NDT = Neurodevelopmental treatment; NW = Nintendo Wii
Fit; OA = Osteoarthritis; TM = Treadmill; TT = Tinetti Test; TUG = Timed Up and Go; Tx = Treatment; SIBT = Sensory Integration Balance
Training; SOT = Sensory organization test; VR = virtual reality; WK = Weeks.
In the experimental groups, NIVR consisted of a combination of treadmill train-
ing [37,38,42,46], conventional exercise programs [39], neurodevelopmental exercises [45]
and functional electrical stimulation [45]. Treatment was carried out at home [41,44], and us-
ing NIVR alone [40,43]. In two studies, the NIVR program was applied at home [41,44], and
in the remaining studies it took place in a clinical and experimental setting [37–40,42,43,45,46].
Several outcome measures were used to assess the efficacy of NIVR rehabilitation in the
management of patients with PD. In five studies, the outcome measure was the number of
falls [37,38,41,42,46]. There were significant differences in the number of patient-reported
falls between the intervention and control groups in three of these studies [38,42,46].
3.3. Methodological Quality of Included Studies
The 10 studies [37–46] included in this systematic review were assessed for their
methodological quality and risk of bias using the PEDro scale [35,36], as described in
Table 5. The methodological quality of the included studies ranged from 4 to 8 on a scale of
11; criterion 1 of illegibility was not considered for the total score. The mean score was 6.1,
which shows good overall methodological quality. No article showed low methodological
quality, three studies were of moderate methodological quality [37,38,45], seven were
moderate to high [39–44,46], and none was rated excellent.
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Table 5. Assessment of methodological quality and risk of bias on the PEDro scale [35,36].
Study Criterion Total Score1 2 3 4 5 6 7 8 9 10 11
Del Din et al. (2020) [37] NO YES NO YES NO NO NO NO YES YES YES 5
Pelosin et al. (2020) [38] YES YES YES NO NO NO YES NO NO YES NO 4
Santos et al. (2019) [39] YES YES NO YES NO NO YES YES YES YES YES 7
Feng et al. (2019) [40] YES YES NO YES NO NO YES YES YES YES YES 7
Gandolfi et al. (2017) [41] YES YES NO YES NO NO YES YES NO YES YES 6
Mirelman et al. (2016) [42] YES YES YES YES NO NO YES YES YES YES YES 8
Negrini et al. (2016) [43] YES NO NO NO NO YES YES YES YES YES YES 6
Yang et al. (2016) [44] YES YES NO YES NO NO YES YES YES YES YES 7
Lee et al. (2015) [45] NO YES NO YES NO NO NO NO NO YES YES 4
Liao et al. (2015) [46] YES YES YES YES NO NO YES YES NO YES YES 7
Data extracted from PEDro database. Criteria: 1, Eligibility criteria were specified (not used for score); 2, Subjects were randomly allocated
to groups; 3, Allocation was concealed; 4, Groups were similar at baseline regarding the most important prognostic indicators; 5, There was
blinding of all subjects; 6, There was blinding of all therapists who administered the therapy; 7, There was blinding of all assessors who
measured at least one key outcome; 8, Measures of at least one key outcome were obtained from more than 85% of the subjects initially
allocated to groups; 9, All subjects for whom outcome measures were available received the treatment or control condition as allocated
or, where this was not the case, data for at least one key outcome was analyzed by ‘intention-to-treat’; 10, The results of between-group
statistical comparisons were reported for at least one key outcome; 11, The study provides both point measures and measures of variability
for at least one key outcome).Yes criteria met; No: criteria not met.
3.4. Results of the Included Studies
3.4.1. Balance
Balance was analyzed using different scales in seven of the 10 studies [39–41,43–46].
The BBS was used to assess the static and dynamic balance skills of patients diagnosed
with PD [39–41,43–45], the ABC scale was used to assess balance confidence in specific
activities [41], one study used the Tinetti scale to assess balance and gait [43], and finally, one
study tested sensory organization and dynamic balance using a dynamic posturography
system called the Balance Master (NeuroCom International Inc., Clackamas, OR, USA) [46].
Three of the studies analyzed found no significant differences in balance between the
intervention groups and the control group. [39,43,44].
Yang et al. [44] reported an improvement in balance in the group performing home
NIVR compared to the group performing a traditional physical therapy program. This
is consistent with the findings of Gandolfi et al., [41] who observed significantly greater
improvement in the home NIVR group versus the group receiving sensory integration
balance training.
After six weeks of treatment, Lee et al. [45] found significant improvement in balance
in the group undergoing NIVR in combination with neurodevelopment therapy and
functional electrical stimulation. In contrast, the control group that underwent combined
neurodevelopmental therapy and functional electrical stimulation showed no statistically
significant improvements.
Liao et al. [46] performed a study with three intervention groups. The experimental
groups performed a conventional exercise program combined with treadmill training or
NIVR combined with treadmill training, and were compared to a control group who only
received a fall prevention educational program. The authors found significant differences
between the experimental groups and the control group in terms of dynamic balance and
sensory organization (evaluated using a clinical posturology instrument).
3.4.2. Risk of Falls
Pelosin et al., [38] similar to Mirelman et al., [42] reported an improvement in the
number of falls in the experimental group after NIVR treatment combined with treadmill
training compared to the treadmill-only group.
In a study with three intervention groups, Liao et al. [46] observed an improvement in
the number of falls in the group performing NIVR in combination with treadmill training
compared with the control group, which only received fall prevention education. However,
they found no difference between the group performing NIVR combined with treadmill
training and the group performing conventional exercises plus treadmill training.
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Five studies [39,40,43,44,46] evaluated the risk of falls using the TUG test [39,40,44,46]
and the functional range of motion test [43]. In three of these studies, the authors ob-
served no significant differences in the risk of falls between the intervention and control
groups [39,43,44].
Feng et al. [40] found significant differences between the intervention group perform-
ing NIVR compared to a traditional physiotherapy program.
Liao et al. [46] observed that the risk of falls in the group performing NIVR com-
bined with treadmill training improved with respect to the control group receiving fall
prevention education.
4. Discussion
Parkinson’s disease is a movement disorder characterized by disordered communi-
cation between the visual, vestibular, and proprioceptive systems. Posture deficits are
also frequently observed in these patients. Postural stability is known to depend on good
coordination between the visual, vestibular and proprioceptive systems [47].
Since PD is a chronic progressive disease, rehabilitation is a long process that requires
patient cooperation. One of the advantages of VR in the rehabilitation of PD patients is
that it maintains patient motivation, resulting in a useful tool for long-term treatments and
to maintain gait and postural performance in PD patients.
The present work has analyzed 10 CRT studies evaluating the effectiveness of NIVR as
intervention strategy for risk of falls and balance rehabilitation in PD patients. The quality
of these studies has been positively rated according to PEDro and comprised a total sample
of 537 PD patients. Additionally, less than 10% of participants dropped out in the original
studies, which can be considered a positive result regarding the adherence to the treatment.
Despite the different approaches to NIVR described in the revised studies, this technique
was found to be effective in improving static and dynamic balance in patients with PD, and
for reducing the rate and risk of falls. The variety of approaches reported in the studies
reviewed also illustrates the nature and diversity of NIVR procedures used in the treatment
of this population and, therefore, supports the clinical validity of our findings.
NIVR has been shown to be more effective than conventional physical therapy for
balance and gait rehabilitation in PD patients [40]. The authors referred that visual feedback
from virtual activities is a relevant factor for PD patients during the rehabilitation process.
Moreover, it has also been observed that NIVR combined with other therapeutic tools,
such as treadmill training [37,38,42,46], conventional exercise [39] or functional electrical
stimulation along with neurodevelopmental treatment [45], significantly improved balance
and reduced falls in PD patients. In the same line, patients following NIVR programs at
home have also shown an improvement in static and dynamic postural control, balance
and walking function [41,44], showing that home-based VR might be a viable option for
PD balance training.
Of the 10 studies included in this review, only Negrini et al. [43] used NIVR in both
treatment groups, with 10 sessions in the control group and 15 in the experimental groups.
These authors found significant differences in balance and fall rates between groups, but
no significant differences in Tinetti test results.
The mean duration of NIVR treatment was 6.8 weeks (range 5 to 12 weeks), with
between two to five sessions per week [37–46]. PD patients received an average of 25 NIVR
sessions [37–46]. However, this treatment intensity places a considerable burden on finan-
cial and human resources.
The physiotherapy evidence database PEDro scores for 7 of the 10 articles included
ranged from 6 to 8, indicating that they are of moderate to high methodological qual-
ity [39–44,46]; the remaining three studies were of moderate methodological quality [37,38,45].
Some authors have found that VR helps PD patients adjust segmental trunk align-
ment [40], while others have reported that VR games can also improve the patient’s stand-
ing stability by improving organization and integration within the vestibular system [48].
Thus, VR games provide dynamic and static posture control activities that help PD patients
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improve control of their trunk and center of gravity, which in turn allows them to adjust
their segmental trunk alignment. Visual feedback in VR games, therefore, allows patients
to sense their own position and direction of movement in space based on visual tracking
and to coordinate their body position. Some authors claims that multisensory perceptual
feedback in VR rehabilitation promotes neural networking in cortical and subcortical areas
of the brain [49]. Neuroimaging studies have shown that virtual motion can activate
motion-related areas in the brain, a finding that supports its role in rewiring and reorga-
nizing the affected brain circuits [50]. Thus, VR combined with immediate multisensory
feedback facilitates task repetition and drives neural changes in the corresponding cortex.
This reduces the fear of falling, and transfers this confidence into the real world through
motor learning [51]. Amirthalingam et al. [52] recently suggested that task repetition using
VR increases neural plasticity in both post-stroke patients and patients diagnosed with
Parkinson’s disease
It is imperative to mention that studies included in this review present several weak-
nesses and methodological limitations. The first concern is the reduced sample size, ranging
between 20 and 130 patients. In addition, the method used to determine the sample size
was not reported in some studies, thus limiting the external validity of their findings. In all
but one of the studies, the treating therapists were not blinded [43]. In two studies, there
was no confirmation that assessors measuring at least one of the key outcomes had been
blinded [37,45], and there was no mention of patient blinding in any of the studies [37–46].
Although these shortcomings may have increased the risk of bias in these studies, it
may not be feasible to blind participants or therapists in a clinical trial using this treatment
tool. Furthermore, some important outcomes, such as balance or the number of falls, were
not evaluated in all the studies reviewed.
We believe that more research is needed to evaluate the effectiveness of NIVR on
these treatment outcomes in patients with PD. This systematic review also has certain
limitations. We only included studies published in English; therefore, we cannot be sure
that relevant scientific literature published in different languages was not overlooked.
Furthermore, as we only included studies we had full access, relevant information about
the effectiveness of NIVR in PD patients may have been overlooked. To the best of our
knowledge, this is the first review of scientific evidence on the effectiveness of NIVR
as a tool for improving balance and reducing the number and risk of falls in patients
diagnosed with EP. Professionals in the field of neurorehabilitation should be aware of the
outcomes achieved with NIVR devices in the treatment of PD, since evidence has shown
that it can be a valuable tool in the context of rehabilitation programs. Thus, NIVR alone
has shown to be more efficient than traditional intervention programs [40]. Additionally,
NIVR increases the effectiveness of other therapies such as treadmill training [37,38,42,46],
exercises programs [39,44] or functional electrical stimulation [45] producing a larger effect
on the risk of falls and balance compared to their application alone.
5. Conclusions
The studies analyzed show that NIVR-based therapy programs lasting between 6 and
12 weeks can significantly reduce the number of falls in PD patients. Although the mixed
results reported in these studies show that there is no clear evidence about the superiority
of NIVR over other therapies, such as exercise programs or conventional physiotherapy.
NIVR combined with treadmill training has proven more effective than NIVR alone.
Home NIVR rehabilitation programs have shown to be effective in preventing falls
and improving balance in PD patients.
Nevertheless, future studies about NIVR programs should be conducted in larger and
more homogeneous samples. Moreover, studying patients following NIVR programs in
isolation would help determine the effectiveness of this therapeutic approach. In the same
line, the most efficient intervention protocol using NIVR should be defined, also comparing
the effectiveness of different NIVR tools. Moreover, it will be fundamental that control
protocols are carried out in a more homogeneous way and defined with more detail.
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